Skip to main content
. 2018 Sep 11;57(40):13330–13334. doi: 10.1002/anie.201806343

Scheme 5.

Scheme 5

a) Iterative substitution of phosphonates. b) Preparation of biologically active phosphonylated targets. c) Deprotection of the nosyl phosphonamidate.